Reproductive options for HIV-serodiscordant couples. (Letters).

By: Bujan, Louis,Daudin, Myriam,Pasquier, Christophe
Publication: Perspectives on Sexual and Reproductive Health
Date: Friday, March 1 2002

The study by James L. Chen and coauthors recently published in Family Planning Perspectives [Fertility desires and intentions of HIV-positive men and women, 2001, 33(4): 144-152 & 165] shows that many HIV-infected adults desire and expect to have children. This is the first study about HIV-positive

men's desire to have children that is based on a nationally representative sample of HIV-infected adults receiving treatment. The results demonstrate that individuals' social and demographic characteristics, as well as health factors related to the desire to have children, have important implications for family planning counseling and access to medical care.

Because a majority of HIV-positive men and women who expect to have children have a partner or spouse who is HIV-negative or whose HIV status is unknown, medical counseling to help them to avoid or reduce the risk of heterosexual transmission of HIV is necessary. When an HIV-infected woman is inseminated with sperm collected from a noninfected partner (either by injecting the sperm herself during ovulation or by using a medically assisted reproductive method), the risk of HIV transmission to the male is avoided. In serodiscordant couples with an HIV-infected male partner, the risk of heterosexual transmission could be avoided or dramatically reduced through the use of insemination with prepared and virologically tested spermatozoa. Insemination with "washed spermatozoa" in such couples was first reported in 1992 in the Lancet, (1) at a time when sperm virology testing was not available. In recent years, dramatic advances in virological methods have led to efficient detection of HIV nucleic acid (RNA and proviral DNA) in seminal plasma and sperm cells. (2)

Using two successive methods of sperm preparation--density gradient method followed by swim-up method--we are able to obtain motile spermatozoa with no HIV nucleic acid detected. In 101 prepared sperm samples, HIV nucleic acid was detected in no final motile spermatozoa, regardless of whether it was present in native sperm. (3) These methods are currently used in several centers. (4) In our group, we have performed 93 insemination cycles on 39 couples, which resulted in 18 pregnancies without HIV transmission to the female partner. (5)

We think these possibilities should be explained to serodiscordant couples planning their family, in order to avoid the risk of heterosexual transmission. Service providers must offer or refer these methods to serodiscordant couples. As a matter of health policy to reduce the risk of sexual HIV transmission, this counseling should be offered along with counseling that serodiscordant couples use condoms during every act of intercourse.

Louis Bujan
Myriam Daudin
CECOS Midi-Pyrenees
Research Group on Human Fertility
University Hospital
Toulouse, France

Christophe Pasquier
Department of Virology
University Hospital
Toulouse, France

REFERENCES

(1.) Semprini AE et al., Insemination of HIV-negative women with processed semen of HIV-positive partner, Lancet, 1992, 340(8831):1317-1319.

(2.) Pasquier C et al., Sperm washing and virus nucleic acid detection to reduce HIV and hepatitis C virus transmission in serodiscordant couples wishing to have children, AIDS, 2000, 14(14):2093-2099.

(3.) Ibid.; and Pasquier C et al., Sperm washing and virus nucleic acid detection to reduce HIV and HCV transmission in serodiscordant couples (male partner infected) wishing children, Fertility and Sterility, 2000, 74(3, Suppl. 1):S68-S69.

(4.) Semprini AE et al., 1992, op. cit. (see reference 1); Marina S et al., Human immunodeficiency virus type 1-serodiscordant couples can bear healthy children after undergoing intrauterine insemination, Fertility and Sterility, 1998, 70(1):35-39; Gilling-Smith C et al., Assisted reproduction in HIV serodiscordant couples, AIDS Reader, 2000, 10(10):581-587; Daudin M et al., Le protocole ANRS 096: prise en charge en assistance medicale a la procreation des couples serodifferents dont l'homme est infecte par le VIH, Reproduction Humaine et Hormones, 2001, 14(6):365-369; and Jouannet P et al., Assisted reproduction for HIV- and/or HCV-infected patients, in: Healy DL et al., Reproductive Medicine in the Twenty-First Century, London: Parthenon, 2001.

(5.) Daudin M et al., 2001, op. cit. (see reference 4).

Related Articles

  • NAT for organs, tissue.
  • Routine nucleic acid testing of organ and tissue donors could improve viral safety in transplant procedures, a study suggests. Such testing is currently used for screening pooled blood donations for hepatitis C virus (HCV) RNA and HIV RNA, and studies ......
  • RNA challenges cancer....
  • In laboratories around the world, researchers are taking a fresh look at RNA, a nucleic acid made from a single strand of chemical components called nucleotides. Cells normally use the nucleotide sequences of RNA strands to transfer the protein-building instructions ......
  • BOSTON PROBES GETS PATENT FOR PNA PROBE TECHNOLOGY.
  • Boston Probes Inc., Bedford, Mass., has announced the issuance of US Patent No. 6,110,676 jointly to Boston Probes & DAKO A/S. This patent describes a new and powerful application of Peptide Nucleic Acid (PNA) probe technology. The broadly claimed methods ......
  • Millipore, Gen-Probe expand partnership.
  • Billerica, MA-based Millipore Corp., a provider of products and services for laboratories, and San Diego, CA-based GenProbe Inc., a nucleic acid test manufacturer, announced an agreement in which Millipore will market and sell Gen-Probe's Mycoplasma Tissue Culture Non-Isotopic (MTC-NI) test....
  • HIV testing.
  • Adding nucleic acid amplification testing to standard HIV antibody testing improves detection of acute HIV infection, according to Christopher D. Pilcher, M.D., of the University of North Carolina at Chapel Hill and his colleagues. In a 12-month multicenter observational study, ......
  • Procleix HIV-1/HCV assay. (New & Approved).
  • (Gen-Probe and Chiron) A nucleic acid amplification test (NAT) system for screening whole-blood donors for HIV-1 and hepatitis C virus (HCV) simultaneously. The system detects these viruses at the very early stages of infection before antibodies or viral antigens appear....
  • The Psychology of Couples and Illness: Theory, Research, and Practice.
  • Edited by Karen B. Schmaling and Tamara Goldman Sher Washington, D.C. American Psychological Association 2000, 407 pp. Frankly, this book at first glance appeared tedious. I thought I was going to have to get interested in knowing a little too ......
  • Synthesis of a novel metal-dependent oxygen-activated nuclease. (Chemistry Poster Abstracts).
  • Andrea C. Clements* Over the past two decades, there has been an increasing interest in synthetic nucleic acid cleaving agents. The synthesis of a metal-dependent oxygen activator, using ruthenium as the metal of choice, is the goal of this project....
  • ...And in the form of catalytic RNA.
  • In another anti-gene approach, scientists make their own ribozymes--bits of catalytic RNA that chew up other strings of this nucleic acid (SN: 12/22&29/90, p.390). They design each ribozyme to target a specific messenger RNA, usually an RNA generated by mutated ......
  • Antigen Retrieval Techniques: Immunohistochemistry and Molecular Morphology.
  • Antigen Retrieval Techniques: Immunohistochemistry and Molecular Morphology Edited by Shan-Rong Shi, Jiang Gu, and Clive R. Taylor, 353 pp, with illus, Natick, Mass, Eaton Publishing, 2000. Antigen Retrieval Techniques is a timely overview of antigen and nucleic acid retrieval methods ......
  • CERUS EXPANDS PATENT COVERAGE FOR PATHOGEN INACTIVATION.
  • Cerus Corporation (Nasdaq:CERS), Concord, Calif., has announced that the U.S. Patent and Trademark Office has issued a patent to Cerus that expands its patent coverage for methods to inactivate viruses, bacteria and parasites in blood products using compounds that bind ......
  • Hybrid Capture II Chlamydia Test.
  • (Digene) A nucleic acid probe-based assay for detecting Chlamydia trachomatis in cervical specimens for use in women with and without symptoms. * Recommended Usage: For use with an endocervical brush called a cervical sampler and swab specimen collection kit also ......
  • Electrochemical DNA-based biosensors: terms and methodology.
  • Biosensors based on deoxyribonucleic nucleic acid (DNA) are well recognized among the family of chemical sensors. With respect to the specific role of DNA in organisms, there are some remarkable specific features of DNA-based biosensors that are applied mainly to ......
  • Hybrid Capture II Chlamydia Test.
  • (Digene) A nucleic acid probe-based assay for detecting Chlamydia trachomatis in cervical specimens for use in women with and without symptoms. * Recommended Usage: For use with an endocervical brush called a cervical sampler and swab specimen collection kit, also ......
  • Sperm washing. (HIV & Pregnancy Update).
  • There's been a lot of buzz about the potentials of "sperm washing," an insemination technique that allows HIV-negative women with positive male partners ("serodiscordant" or "magnetic" couples) to safely get pregnant. A center in Milan, Italy, has been on the ......

Related Topics